Researcher’s Profile

Top Doctor: 

Tony J. Wang, MD

Co-Director, Center for Radiosurgery

Tony Wang, M.D., is the Co-Director of the Center for Radiosurgery and an Associate Professor of Radiation Oncology (in Neurological Surgery) at New York Presbyterian/Columbia University Medical Center. Dr. Wang cares for patients with all types of cancer, with extensive expertise in malignant and benign brain tumors. His research interests are in Gamma Knife stereotactic radiosurgery and brain tumors.

Dr. Wang received his B.A. and M.D. degrees from University of Missouri Kansas City Medical School, during which time he was also a Clinical Research Training Program Fellow at the National Institutes of Health, Bethesda, Maryland. He received internship training at Flushing Hospital Medical Center. Dr. Wang received his radiation oncology training at New York Presbyterian Hospital (Columbia campus), where he was Chief Resident from 2011-2012.

As a member of the Brain Tumor Center, Gamma Knife Center, and Pituitary Tumor Center, Dr. Wang is part of a multidisciplinary team that brings expertise from multiple specialties, including neurosurgery, neuro-oncology, neuroradiology, and neuro-endocrinology.

He serves as a reviewer for various medical journals and is a member of several medical societies.


Nanda T, Yeah A, Wu CC, Jani A, Saad S, Qureshi YH, Cauley KA, Lesser J, Cheng SK, Isaacson SR, Sisti MB, Bruce JN, McKhann GM, Sheth SA, Lassman AB, Wang TJ. Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease. Journal of Neuro-Oncology. 2017.

Nanda T, Wu CC, Campbell AA, Bathras RM, Jani A, Kazim M, Wang TJ. Risk of dry eye syndrome in patient striated with whole-brain radiotherapy. Medical Dosimetry. 2017; 42:357-362.

Wu CC, Chaudhry KR, Na YH, Welch D, Black PJ, Sonabend AM, Canoll P, Sanger YM, Wang TJC, Wuu CS, Hei TK, Cheng SK. Quality assessment of stereotactic radiosurgery of a melanoma brain metastases model using a mouse-like phantom and the small animal radiation research platform. International Journal of Radiation Oncology, Biology and Physics. 2017; 99:191-201.

Smith DR, Wu CC, Wang TJC. Stereotactic radiosurgery for treatment of multiple brian metastases: remembering to spare the hippocampus? In regard to Zhang et al. Practical Radiation Oncology. 2017; 7:446-447.

Saraf A, Grubb CS, Hwang ME, Tai CH, Wu CC, Jani A, Lapa ME, Andrews, JIS, Vanderkelen S, Isaacson SR, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Connolly EP, Wang TJC. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development. Journal of Neuro-Oncology. 2017; 134:453-463.

Wu CC, Smith DR, Chin C, Wang TJ. The success of nrg-gbm-rpa: biomarker-based classification, where to next? Translational Cancer Research. 2017; 6:S541-543.

Perni S, Wang TJ, Lesser J, Mandigo C, Isaacson SR, Horowitz DP. Gamma knife treatment of recurrent CNS metastases of pancreatic origin: a case report and review of the literature. CNS Oncology. 2017; 6:111-118.

Wu CC, Wuu YR, Jani A, Saraf A, Tai CH, Lapa ME, Andrew JIS, Tiwari A, Saadatmand HJ, Isaacson SR, Cheng SK, Wang TJC. Whole-brain irradiation field design: a comparison of parotid dose. Medical Dosimetry. 2017; 42:145-149.

Kinslow CJ, Rajpara RS, Wu CC, Bruce SS, Canoll PD, Wang SH, Sonabend AM, Sheth AM, McKhann GM, Sisti MB, Bruce JN, Wang TJC. Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system. Journal of Neuro-Oncology. 2017; 133:409-417.

Yanagihara TK, Lee A, Wang TJ. Quantitative analysis of the spatial distribution of metastatic brain lesions. Tomography. 2017; 3:16-22.

D'Amico RS, Zanazzi G, Hargus G, Dyster T, Chan S, Lignelli-Dipple A, Wang TJ, Faust PL, McKhann GM. Intracranial intraaxial cerebral tufted angioma: case report. Journal of Neurosurgery. 2017.

D'Amico RS, Banu MA, Petridis P, Bercow AS, Malone H, Praver M, Wang TJ, Isaacson SR, Sisti MB. Efficacy and outcomes of facial nerve-sparing treatment approach to cerebellopontine angle meningiomas. Journal of Neurosurgery. 2017; 127:1231-1241.

Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJ, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: nrg oncology rtog 0525 and 0825. Neuro-Oncology. 2017; 19:669-677.

Yanagihara TK, Saadatmand HJ, Wang TJ. Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation. Journal of Neuro-Oncology. 2016; 130:397-411.

Yanagihara TK, Grinband J, Rowley J, Cauley KA, Lee A, Afghan M, Chu A, Wang TJ. A simple automated method for detecting recurrence in high-grade glioma. American Journal of Neuroradiology. 2016; 37:2019-2025

Garrett MD, Wu CC, Yanagihara TK, Jani A, Wang TJ. Radiation therapy for the management of brain metastases. American Journal of Clinical Oncology. 2016; 39:416-422.

Jani A, Wang TJ, Sisti MB. In reply: how long should we wait for delivery treatment after surgery? An enigma yet to be solved. Neurosurgery. 2016; 79:E166-167.

Wang TJ, Wu CC, Jani A, Estrada J, Ung T, Chow DS, Soun JE, Saad S, Qureshi YH, Gartrell R, Saadatmand HJ, Saraf A, Garrett MD, Grubb C, Isaacson SR, Cheng SK, Sisti MB, Bruce JN, Sheth SA, Lassman AB, Iwamoto FM, McKhann GM 2nd. Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with new